Generex Posts Net Loss in Second Quarter
On March 11, 2009, Generex Biotechnology reported that its Q2 FY09 net loss widened due to the interest expense and repricing costs of warrants costs issued in connection with convertible debentures and an ...
Join the discussion below, or Read more at TheStreet.com.
#1 Mar 13, 2009
Sales have increased greatly. This company has so much potential. They hold patent # 7070799 on the process and rights to deliver doses of large molecule drugs through the buccal mucosa, or inner lining of the mouth. LLY left this company to die, but they didn't nor should they die. There is much pressure for the FDA to approve their flagship product, Oral-Lyn, delivered through a small hand held Rapid Mist sprayer. People and especially children will enjoy receiving insulin in this painfree manner and the sprayer is similar in size to asthma inhalers people are used to seeing. There will be no pain for the insulin injections, no deposit into the lungs and the medicines delivered through the buccal mucosa go directly into the bloodstream. Think of how fast nitro glycerine goes into the bloodstream(a bit different) but easy to understand. Read about Dr. Bernstein and his dedication working to make it possible for people to receive insulin and other large molecule drugs throught the buccal mucosa, inner lining of the cheek. It is safer and much easier than swallowing a pill. Think of the billions of people who want these advances!
#2 Apr 20, 2009
I agree 100% that GNBT has a great conceptwith not only oral-lyn, but with utilizing the buccal mucosa to deliver medications in general. I think in this day in age when hospitals are very concerned with "pain management" and the comfort of their patients, GNBT has a solution which is in line with that initiative. You wrote on how children would benefit taking away the pain of shots and fear of needles, but how about elderly whose veins are virtually unfindable or unable to be used due to frailty. GNBT has given the medical industry a great alternative, unfortunatly the pharm. industry who abandened GNBT already may stick their money loving noses in this and try their hardest to stop such a great advancement. Lets face it the Pharm industry motto seams to be "it may be great for everyone, but if we dont greatly benefit no one will." So lets pray for one of these weasles to pick GNBT up so all of this can be a reality and not just a sad shame.
#3 Mar 7, 2010
Believe me, no one wants this company to succeed more than I do. However, I have been investing for thirty years. I have seen great hype on plenty of companies, and none of them ever panned out. Lets pray this one does!!!!
Add your comments below
|Market Maker Surveillance Report. GNBT, PFE, JP... (Feb '13)||Feb '13||jagdish||1|
|Generex Biotechnology Corporation Announces App... (Jun '11)||Jul '12||davidflora||2|
|reverse stock split (Mar '11)||Jun '11||RSL||3|
|oralyn (Mar '11)||Mar '11||rainking65||1|
|Generex to Release Material Announcement on Oct... (Oct '10)||Oct '10||WTF||1|
|Oral Recosulin (Jan '09)||Jan '09||Azeem||1|
|Free Biotechnology Magazine (Aug '08)||Aug '08||Biotech||1|
Find what you want!
Search Generex Biotechnology Forum Now
Copyright © 2018 Topix LLC